Nanalysis Scientific Corp
XTSX:NSCI
Nanalysis Scientific Corp
XTSX:NSCI
Price:
0.465 CAD
5.68%
Updated:
May 6, 2024
Nanalysis Scientific Corp
Cash from Financing Activities
|
Nanalysis Scientific Corp
Cash from Financing Activities Peer Comparison
Comparables:
NVCN
PRN
OPS
VPT
MIR
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Nanalysis Scientific Corp
XTSX:NSCI
|
Cash from Financing Activities
CA$13.2m
|
CAGR 3-Years
17%
|
CAGR 5-Years
128%
|
CAGR 10-Years
N/A
|
|
|
Neovasc Inc
TSX:NVCN
|
Cash from Financing Activities
-$762.3k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Profound Medical Corp
TSX:PRN
|
Cash from Financing Activities
$1.5m
|
CAGR 3-Years
-74%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
N/A
|
|
|
Opsens Inc
TSX:OPS
|
Cash from Financing Activities
CA$10.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
18%
|
|
|
VentriPoint Diagnostics Ltd
XTSX:VPT
|
Cash from Financing Activities
-CA$60.2k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
MedMira Inc
XTSX:MIR
|
Cash from Financing Activities
CA$2.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
29%
|
CAGR 10-Years
-7%
|
See Also
What is Nanalysis Scientific Corp's Cash from Financing Activities?
Cash from Financing Activities
13.2m
CAD
13.2m
CAD
Based on the financial report for Dec 31, 2022, Nanalysis Scientific Corp's Cash from Financing Activities amounts to 13.2m CAD.
What is Nanalysis Scientific Corp's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
128%
128%
Over the last year, the Cash from Financing Activities growth was 12%. The average annual Cash from Financing Activities growth rates for Nanalysis Scientific Corp have been 17% over the past three years , 128% over the past five years .
You don't have any saved screeners yet
